Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03707197 · ClinicalTrials.gov registry record · NA
Guided Meditation and Stress-Induced Eating
A NA study of Stress-induced Eating, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 943
- Enrollment target
- 1
- Study location
NCT03707197: Completed NA study of Stress-induced Eating, sponsored by University of California, Los Angeles.
NCT03707197 is a NA study of Stress-induced Eating that has completed, run by University of California, Los Angeles. The registered enrollment target is 943 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03707197, a NA study of Stress-induced Eating, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 943 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to test the effects of a digital meditation intervention in a sample of UCLA employees who report mild to moderate stress. We will randomize University of California Los Angeles employees to either 8-weeks of a digital meditation intervention (using the commercially available application Headspace) or a waitlist control condition.
Primary Outcome
Changes in the Perceived Stress Scale (range: 1-40; Cohen, Kamarck, \& Mermelstein, 1988). Higher scores indicate greater psychological distress.
Conditions Studied
Interventions
- BEHAVIORAL Meditation
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 943 participants |
| Start Date | 2018-10-15 |
| Est. Completion | 2020-09-11 |
| Phase | NA |
What the finished NCT03707197 record still lists
NCT03707197 is an interventional study that assigns participants to a tested intervention. The registered 943 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (33% lower).
The record links to 1 condition, with Stress-induced Eating appearing as the primary indexed condition, and to 1 intervention - of which Meditation is the first listed.
NCT03707197 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03707197 about?
NCT03707197 is a clinical study titled "Guided Meditation and Stress-Induced Eating". The aim of this study is to test the effects of a digital meditation intervention in a sample of UCLA employees who report mild to moderate stress. We will randomize University of California Los Angeles employees to either 8-weeks of a digital meditation intervention (using the commercially availabl...
What is the current status of trial NCT03707197?
This trial is currently completed. It is a NA study. The enrollment target is 943 participants. The study started on 2018-10-15. Estimated completion is 2020-09-11.
What conditions does trial NCT03707197 study?
This clinical trial studies the following conditions: Stress-induced Eating.
What interventions are being tested in trial NCT03707197?
The interventions under investigation include: Meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03707197?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03707197 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03707197's enrollment target sits among peer trials
943 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05020236 · 944 participants · Phase 3
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- NCT06808334 · 942 participants
CLAiR Pivotal Study
- NCT07190209 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- NCT07190222 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI